OVID
Ovid Therapeutics Inc.
Company Overview
| Mkt Cap | $105.95M | Price | $1.39 |
| Volume | 1.70M | Change | +1.46% |
| P/E Ratio | -4.0 | Open | $1.36 |
| Revenue | $566.0K | Prev Close | $1.37 |
| Net Income | $-26.4M | 52W Range | $0.24 - $2.01 |
| Div Yield | N/A | Target | $4.50 |
| Overall | 63 | Value | 60 |
| Quality | -- | Technical | 66 |
No chart data available
Stock Overview
Updated DailyOvid Therapeutics Inc. (OVID) is a leading Healthcare company in the Biotechnology industry, currently trading at $1.39 with a market capitalization of $105.95 million. The stock is positioned in the upper portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows OVID with a volume of 1.70 million shares. The stock opened down 0.73% from yesterday's close of $1.37. Current analyst estimates project earnings of $-0.44 per share for this year, with next year targeting $-0.41.
OVID demonstrates positive technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for OVID include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 223.7%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 12:30 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OVID | $1.39 | +1.5% | 1.70M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |